About 10-12 months ago, I posted feedback from a drug discovery pharmacologist with pessimism re NKTR. I did take my share of flack - perhaps because it was not my own analysis ( I know nothing about drug development). Anyway, I resolved to hold NKTR for about a year and monitor the company.
I sold all my NKTR last week and will use the loss to offset my other capital gains.
My learnings:
-
Stay away from companies I have zero understanding of - for me, that includes drugs, mining, and consumer goods / retailers.
-
When Saul and company sell, I should just plain sell and not wait for my initially planned hold period nor some clear change that shows that the investment thesis no longer applies.
…Marc